retatrutide ly3437943 glp-1 gip glucagon Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature Retatrutide (LY3437943), a Novel GIP/GLP-1/Glucagon
Description
Epicardial Adipose Excision Slows the Progression of Porcine Coronary Atherosclerosis
[DOI] [PMC free article] [PubMed] [Google Scholar] 250.Waterlander W.E., Jiang Y., Nghiem N., Eyles H., Wilson N., Cleghorn C., Genc M., Swinburn B., Mhurchu C.N., Blakely T
Lancet Neurol, 16:425-434
Will taking GLP-1 every other week affect my results
A separate 2025 systematic review and meta-analysis published in the Journal of Thrombosis and Haemostasis analyzed 27 clinical trials involving more than 84,000 patients
